Addressing a serious electrical disorder of the heart, Long QT Syndrome, Mayo Clinic is developing a potentially life-saving device for early detection.

There are several forms of Long QT, ranging in severity and cause.  Some known causes are:

  • More than 100 drugs approved by the Food and Drug Administration (FDA).
  • Genetics, including congenital long QT syndrome.
  • Many systemic diseases, including even SARS-CoV-2-mediated COVID-19.

Original article

Mayo Clinic research yields breakthrough in mobile determination of QT prolongation

MAYO CLINIC

ROCHESTER, Minn. — Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death.  This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient’s heart. The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient’s QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation.

Read the entire article 

Share this article

Facebook
Twitter
LinkedIn

Leave a Reply

Kulman, LLC © All Rights Reserved 2020

Mayo Clinic research yields breakthrough in mobile determination of QT prolongation

My HeartCheck is a medical services organization that provides professional youth heart screenings, including EKGs and echocardiograms.

To help ensure that cost is not a barrier to screening, My HeartCheck works with multiple independent nonprofit organizations that provide charitable support for families and communities in need. These partners include Strive for Life Foundation and the Jordan Robert Mann Foundation, among others.

My HeartCheck automatically applies the first $40 of financial assistance toward every qualifying financial aid screening. When a parent requests financial assistance, the pricing is adjusted immediately using a pre-established aid formula. Additional assistance beyond the first $40 is supported through our charitable partners—including Strive for Life Foundation and the Jordan Robert Mann Foundation—subject to available funding.

In addition to individual financial assistance, My HeartCheck works with multiple nonprofit organizations to support fully funded heart screening events in underserved or high-risk communities. These events are designed to expand access to screenings for children who might otherwise go untested.

My HeartCheck provides the clinical screening services for all screenings and events at standard, fair-market rates. While My HeartCheck and its nonprofit partners are separate organizations with distinct roles, we share a common goal: protecting children by identifying hidden heart conditions early.

Cancellation policy: A full refund for cancellations will be honored if written notice is received at least 5 days prior to your scheduled event. Requests must be sent to info@myheartcheck.org. A full refund, minus a $25.00 processing fee, will be honored for any cancellation requests received less than 5 days prior to your scheduled event. Within 48 hours of your appointment date, we are unable to honor appointment changes or cancellations. No refunds will be provided for missed appointments. ATS reserves the right to cancel a screening event in the unlikely event of insufficient enrolment or other unforeseen circumstances. If an event is canceled or postponed, ATS will provide full refunds for registration fees but cannot be held responsible for other costs or expenses.